|
|
|||
| |||||||||||||||||||||||||||||||||||||
Molecular epidemiology extends traditional epidemiology studies based on questionnaires by incorporating genetic and molecular measures as biomarkers of exposure, risk, and prognosis. The explosion of genetic information and laboratory methods for high-throughput genotyping, gene expression, and proteomics requires new approaches to the design of studies in molecular epidemiology. The design and conduct of large, powerful studies of multiple biomarkers calls for a collaborative approach, and the integration of epidemiology, genomics, proteomics, metabolomics, biostatistics, and bioinformatics requires a shared language. In Molecular Epidemiology, Timothy Rebbeck, Christine Ambrosone, and Peter Shields bring together experts who present to a wide audience of
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |